Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by narmacon Feb 07, 2023 7:00pm
147 Views
Post# 35273217

RE:RE:RE:RE:RE:RE:RE:RE:RE:British Columbia Securities Commission!!

RE:RE:RE:RE:RE:RE:RE:RE:RE:British Columbia Securities Commission!!,,but,,POF,,,,the impressive advanceent of Carina and the disasterous condition Bioasis is in is the CEOs responsibility....unfortunately thats how important positons go...seems everything is falling into place for Carina,,,,,and as they say there is a huge amount of work to get financing and to get an IND in place,,,,,with a 10 to 12 hour difference in time between here and Aussiland,,,what hat and what input was available for Bioasis?.....you cant have your cake and eat it to as they say. The best we would or could get is half a days work in our corner!,,it looks like the majority of work has been into Carina. Or is there little substance to financing and filing an IND??,,which is it?

And one should always refer to the chart to assess if a company can impress ,,, the market likes winners and we seem not to be in that light at the moment!!,,havent you noticed???
<< Previous
Bullboard Posts
Next >>